J Cancer 2022; 13(10):3022-3030. doi:10.7150/jca.73365 This issue Cite

Review

The Role of the S100 Protein Family in Glioma

Haopeng Wang#, Xiang Mao#, Lei Ye, Hongwei Cheng, Xingliang Dai

Department of Neurosurgery, the First Affiliated Hospital of Anhui Medical University, Hefei, 230022, China.
#These authors contributed equally to this work.

Citation:
Wang H, Mao X, Ye L, Cheng H, Dai X. The Role of the S100 Protein Family in Glioma. J Cancer 2022; 13(10):3022-3030. doi:10.7150/jca.73365. https://www.jcancer.org/v13p3022.htm
Other styles

File import instruction

Abstract

Graphic abstract

The S100 protein family consists of 25 members and share a common structure defined in part by the Ca2+ binding EF-hand motif. Multiple members' dysregulated expression is associated with progression, diagnosis and prognosis in a broad range of diseases, especially in tumors. They could exert wide range of functions both in intracellular and extracellular, including cell proliferation, cell differentiation, cell motility, enzyme activities, immune responses, cytoskeleton dynamics, Ca2+ homeostasis and angiogenesis. Gliomas are the most prevalent primary tumors of the brain and spinal cord with multiple subtypes that are diagnosed and classified based on histopathology. Up to now the role of several S100 proteins in gliomas have been explored. S100A8, S100A9 and S100B were highly expression in serum and may present as a marker correlated with survival and prognosis of glioma patients. Individual member was confirmed as a new regulator of glioma stem cells (GSCs) and a mediator of mesenchymal transition in glioblastoma (GBM). Additionally, several members up- or downregulation have been reported to involve in the development of glioma by interacting with signaling pathways and target proteins. Here we detail S100 proteins that are associated with glioma, and discuss their potential effects on progression, diagnosis and prognosis.

Keywords: S100 protein, glioma, progression, diagnosis, prognosis


Citation styles

APA
Wang, H., Mao, X., Ye, L., Cheng, H., Dai, X. (2022). The Role of the S100 Protein Family in Glioma. Journal of Cancer, 13(10), 3022-3030. https://doi.org/10.7150/jca.73365.

ACS
Wang, H.; Mao, X.; Ye, L.; Cheng, H.; Dai, X. The Role of the S100 Protein Family in Glioma. J. Cancer 2022, 13 (10), 3022-3030. DOI: 10.7150/jca.73365.

NLM
Wang H, Mao X, Ye L, Cheng H, Dai X. The Role of the S100 Protein Family in Glioma. J Cancer 2022; 13(10):3022-3030. doi:10.7150/jca.73365. https://www.jcancer.org/v13p3022.htm

CSE
Wang H, Mao X, Ye L, Cheng H, Dai X. 2022. The Role of the S100 Protein Family in Glioma. J Cancer. 13(10):3022-3030.

This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.
Popup Image